Cubist’s latest antibiotic won praise from a panel of FDA advisers, setting the stage for a likely approval and head-to-head competition with Pfizer’s blockbuster Zyvox.

…read more

Source: Cubist’s superbug drug clears FDA panel, lines up for Pfizer showdown